Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Lang Ma
Research Scientist
Epigenetics & Molecular Carcinogenesis
h-index
842
Citations
15
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2016
2023
Research activity per year
Overview
Fingerprint
Network
Research output
(21)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Lang Ma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Yes-associated Protein 1 (YAP1)
100%
Gastric Adenocarcinoma
68%
LncRNA PVT1
56%
Prognosticator
56%
Therapeutic Target
43%
SRY-box Transcription Factor 9 (SOX9)
41%
Galectin-3 (Gal-3)
37%
Coactivator
37%
Hippo
37%
Esophageal Adenocarcinoma
37%
Patient-derived Xenograft
26%
Aggressive Phenotype
23%
Quantitative PCR
22%
Peritoneal Metastasis
22%
Esophageal Cancer
22%
Radiation Resistance
20%
Advanced Gastric Adenocarcinoma
19%
Ascites
18%
T Cell Immunity
18%
Antisense Oligomers
18%
Clinical Setting
18%
Oncogenesis
18%
ARID1A
18%
Mouse Model
18%
Gastric Cancer Progression
18%
Gastroesophageal Carcinoma
18%
Potential Biomarkers
18%
Bromodomain Inhibitors
18%
Dephosphorylation
18%
BET Inhibitor
18%
Cluster of Differentiation 47 (CD47)
18%
Endosomal
18%
GPCR Kinase
18%
Bcl-2 Inhibitor
18%
Normal Development
18%
Breast
18%
Esophageal Carcinoma
18%
ErbB2
18%
Gastric Cancer Peritoneal Metastasis
18%
Diffuse-type Gastric Adenocarcinoma
18%
GOLM1
18%
PCR Method
18%
Cyclin-dependent Kinase 6 (CDK6)
18%
Cyclin-dependent Kinase 4 (CDK4)
18%
AT-101
18%
Plasmacytoma Variant Translocation 1 (PVT1)
18%
Malignancy
18%
Minor Error
18%
MTA3
18%
Bromodomain
18%
Medicine and Dentistry
Stomach Adenocarcinoma
97%
Peritoneum Metastasis
39%
Synapsin I
37%
Esophageal Adenocarcinoma
37%
Xenograft
31%
Cell Line
31%
Cancer Stem Cell
28%
Neoplasm
26%
Carcinomatous Peritonitis
25%
Cancer
22%
In Vitro
22%
Malignant Neoplasm
21%
Upregulation
19%
Breast Cancer
18%
Internalization
18%
Carcinogenesis
18%
Biological Marker
18%
Esophagus Carcinoma
18%
Cellular Immunity
18%
Abdominal Cancer
18%
Dephosphorylation
18%
Esophageal Cancer
18%
Esophageal Squamous Cell Carcinoma
18%
Galectin 3
18%
Ascites
18%
Mechanistic Target of Rapamycin
18%
G Protein Coupled Receptor
18%
Real-Time Polymerase Chain Reaction
18%
Phosphotransferase
18%
Antineoplastic Activity
18%
CDK4/6 Inhibitor
18%
Radiosensitivity
18%
Antisense
18%
Phagocytosis
18%
Cancer Cell
18%
Tumor Progression
16%
Tumor Cell
9%
Stromal Cell
7%
Phosphatase
7%
Colony Formation
7%
Exosome
6%
Treatment Response
6%
Chemoradiotherapy
6%
Progression Free Survival
6%
Tissue Microarray
5%
Macrophage
5%
Biochemistry, Genetics and Molecular Biology
YAP1
77%
SOX9
57%
Cancer Cell
35%
Antisense
29%
Carcinogenesis
24%
RNA
21%
CRISPR/Cas9
20%
Phosphotransferase
20%
Kinase
20%
Bromodomain
20%
Immunity
20%
RNA Sequencing
19%
Upregulation
19%
Internalization
18%
Phosphatase
18%
Synapsin I
18%
Guide RNA
18%
Galectin-3
18%
Dephosphorylation
18%
G Protein Coupled Receptor
18%
T Cell
18%
Development
18%
MTA3
18%
Mechanistic Target of Rapamycin
18%
Peroxisome Proliferator-Activated Receptor
18%
Gene Targeting
18%
Gene Knockout
18%
Tumor Progression
18%
Colony Formation
15%
Cas9
13%
Exome Sequencing
12%
TAF1
12%
Immune Checkpoints
12%
Immunoprecipitation
11%
Oligonucleotide
10%
Oncogene
9%
Cell Membrane
9%
Protein Tyrosine Phosphatase
9%
Target Cell
9%
Azacitidine
9%
Demethylation
9%
Transgenic Mouse
9%
Mouse Mammary Tumor Virus
9%
Binding Site
8%
Esophagus
8%
Immune Response
7%
Cell Proliferation
7%
Antineoplastic Activity
6%
Galectin
6%
Cancer Growth Factor
6%
